Qube Research & Technologies (QRT)’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-226,417
Closed -$3.78M 3176
2022
Q4
$3.78M Buy
+226,417
New +$3.82M 0.02% 734
2022
Q2
Sell
-29,310
Closed -$325K 3308
2022
Q1
$325K Buy
+29,310
New +$328K ﹤0.01% 1745
2021
Q3
Sell
-15,448
Closed -$511K 2962
2021
Q2
$511K Sell
15,448
-5,575
-27% -$210K 0.01% 1285
2021
Q1
$822K Buy
+21,023
New +$987K 0.01% 928

Qube Research & Technologies (QRT)'s ONEM Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 226,417 shares — an estimated $3.78M sold.

Qube Research & Technologies (QRT) first reported a position in ONEM in Q1 2021 and held it in 4 quarters. The position peaked at $3.78M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Qube Research & Technologies (QRT) reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 226,417 1Life Healthcare shares in Q1 2023, an estimated $3.78M.
  • Qube Research & Technologies (QRT) first reported a position in 1Life Healthcare in Q1 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s 1Life Healthcare position peaked at $3.78M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.